In an 83-year-old man with dilated cardiomyopathy, recurrent fever and intense shaking chills were ultimately diagnosed as Enterococcus faecalis infective endocarditis involving his implantable cardioverter-defibrillator (ICD) lead.
This complex case underscores the critical necessity of prioritizing blood cultures and advanced cardiac imaging, even when initial physical examination shows no obvious signs of infection.
The diagnosis poses a major challenge in emergency medicine, where seemingly benign clinical presentations can mask life-threatening systemic infections. This case highlights how a persistent pattern of fever and rigors, coupled with a history of complex cardiac disease, necessitated a shift from ruling out simple inflammation to investigating a severe intracardiac device infection.
Persistent Fever Demands Immediate Blood Testing
- Persistent fever and chills in someone with a heart device require immediate blood testing, regardless of how well they look.
- An infection on a pacemaker or defibrillator lead is often silent and requires specialized imaging, like TEE, to detect.
- Treatments must be aggressive and specific, often requiring consultation across cardiology, infectious diseases, and surgery.
Elderly Patient with Fever and Chills
The patient, an 83-year-old man with known dilated cardiomyopathy, was initially evaluated after experiencing a one-week history of fever and intense chills. His medical history included permanent atrial fibrillation, moderate mitral regurgitation, and a ventricular ICD placed ten years prior for ventricular tachycardia and syncope. His complex medication regimen included agents like carvedilol, apixaban, and sacubitril/valsartan to manage heart failure and anticoagulation.
On arrival at the emergency department, the patient appeared hemodynamically stable, with a blood pressure of 129/62 mm Hg and a temperature of 98.6 °F (37 °C). Key to the diagnostic process, the clinical picture initially offered no clear infectious focus.
The abdomen was soft and nontender, and there were no visible signs of infection in the ICD device pocket, rash, or local inflammation. Standard initial laboratory tests showed mild leukocytosis of 11.8 × 10⁹/L and significantly elevated inflammatory markers, including a C-reactive protein level of 12 mg/L and an erythrocyte sedimentation rate of 141 mm/h.
Despite initial negative results from chest radiography, which showed cardiomegaly but no consolidation, and negative respiratory virus tests, the clinical suspicion remained high. In stable patients with persistent fever and an intracardiac device, obtaining multiple blood cultures is the priority. This strategy ensures that even if a patient is not acutely ill, the pathogen can be identified to guide future antimicrobial therapy.
The definitive microbiological findings arrived when two out of two blood culture sets grew Enterococcus faecalis. Gram staining confirmed gram-positive cocci in chains. Susceptibility testing revealed the organism was susceptible to ampicillin, vancomycin, and teicoplanin, but resistant to ciprofloxacin and levofloxacin. This confirmed the presence of significant bacterial bacteremia.
Visualizing the Infection: The Role of Echocardiography
Following the identification of the pathogen, a transthoracic echocardiogram (TTE) was performed. Although TTE is a reasonable initial screening tool, it did not reveal clear vegetations or masses on the ventricular lead. This lack of clear evidence is common in systemic infections involving intracardiac leads.
The next step involved a transesophageal echocardiogram (TEE), which provided the definitive diagnosis. TEE revealed an 8 × 24-mm mass attached to the proximal segment of the ventricular ICD lead. This lesion is highly compatible with E. faecalis infective endocarditis.
The combination of persistent fever and rigors, confirmation of two serial blood cultures for E. faecalis, and the visualization of an intracardiac mass establishes the definitive diagnosis of device-related infective endocarditis. While a sterile lead thrombus could mimic this appearance, the sustained febrile symptoms and specific bacteremia make the infectious etiology the most clinically probable explanation.
| Clinical Parameter | Patient Result | Normal Reference Range | Implication |
|---|---|---|---|
| Hemoglobin | 9.7 g/dL | 13.5-17.5 g/dL | Chronic Anemia |
| C-Reactive Protein (CRP) | 12 mg/L | < 3.0 mg/L | Significant Inflammation |
| Erythrocyte Sedimentation Rate (ESR) | 141 mm/h | < 20 mm/h | Severe Systemic Inflammation |
| Pathogen | Enterococcus faecalis | N/A | Confirmed Endocarditis |
Clinical Management of Device Infection and Systemic Risk
This case serves as a critical reminder that cardiovascular implantable electronic devices are not immune to systemic infection. The infection can present in the generator pocket, the subcutaneous tract, or directly involving the intracardiac leads without any local signs like erythema or pain. This systemic form is often the most deceptive and requires high clinical suspicion.
Management requires a multidisciplinary approach involving infectious diseases, cardiology, and potentially cardiovascular surgery. Because retained infected material increases the risk for persistent bacteremia, septic embolization, and death, the recommended treatment involves both targeted intravenous antibiotics and the potential extraction of the infected device material. While antibiotics reduce the bacterial burden, they do not always sterilize the leads completely.
Mortality data in related studies highlight the urgency of such cases. A systematic review of outcomes in ICD-related infective endocarditis showed overall mortality rates ranging from 4% to 36%, highlighting the severe, often life-threatening, nature of these infections.
Contraindications & When to Consult a Doctor
The primary risk is that symptoms may be dismissed as typical heart failure exacerbation, even when a serious infection is present.
- Consult a Doctor Immediately If: You experience new or worsening fever, unexplained shaking chills, or rigors (intense shivering) that are not clearly linked to a known respiratory illness.
- Seek Emergency Care If: You have a known cardiac device and notice any unexplained discomfort, drainage, or redness near the generator pocket, even if your fever is currently low.
- Avoid Self-Medication: Do not attempt to treat persistent fever or chills with over-the-counter medications without consulting your cardiologist or primary care physician, as this can mask critical diagnostic signs.
The 2024 American Heart Association scientific statement emphasizes combining clinical, microbiologic, and imaging findings to diagnose device-related infection. In the absence of a clear local source, persistent fever is a powerful indicator that systemic evaluation for endocarditis is necessary.
The Future of Infection Prevention
The diagnosis of device lead endocarditis is complex because it requires the integration of three distinct pieces of evidence: persistent clinical signs (fever/rigors), definitive microbiology (positive serial blood cultures), and specific imaging findings (TEE mass). Failing to recognize the combination of these factors can lead to delayed treatment and increased mortality.
Public health efforts focus on preventing infections in high-risk populations through strict adherence to prescribing guidelines and promoting rigorous post-procedure monitoring. For patients with CIEDs, proactive communication with their healthcare providers about any subtle changes in health is the most effective preventative measure.
Ultimately, the management of this case—moving from initial stabilization to targeted antibiotic therapy guided by E. faecalis susceptibility and confirmed by TEE—exemplifies the rigorous, evidence-based approach required in modern critical care. The timely identification of the 8 × 24-mm mass on the ICD lead prevented potentially catastrophic outcomes associated with untreated infective endocarditis.
References
- Evidence for diagnostic criteria for infective endocarditis in implantable device patients.
- The 2023 European guidelines on infective endocarditis.